Nicotine receptor partial agonists for smoking cessation

Cahill, K, Stead, LF, Lancaster, T·2007·Cochrane Database of Systematic Reviews
DOI 10.1002/14651858.cd006103.pub2

Cites (245)

Items 201–245 of 245

  1. Flexible and extended dosing of nicotine replacement therapy or varenicline in comparison to fixed dose nicotine replacement therapy for smoking cessation: Rationale, methods and participant characteristics of the FLEX trial
    Heather E. Tulloch, Andrew Pipe, Charl Els, Debbie Aitken, Matthew J. Clyde, Brigitte Corran, Robert D. Reid · 2014 · Contemporary Clinical Trials
  2. The place of varenicline in smoking cessation treatment
    Paul N Aveyard · 2008 · Thorax
  3. [Medical support of nicotine withdrawal. Report on a double blind trail in over 5000 smokers (author's transl)].
    F Schmidt · 1974 · PubMed
  4. AUSTRALIA'S EXPERIENCE WITH VARENICLINE: USAGE, COSTS AND ADVERSE REACTIONS
    Raoul A. Walsh · 2011 · Addiction
  5. Comment and Reply: A double-blind study evaluating the long-term safety of varenicline for smoking cessation
    John G. Spangler, K. E. Williamsa, K. R. Reeves, CB Billing, ANN PENNINGTON, Jinxia Gong · 2008 · Current Medical Research and Opinion
  6. Examination of the mechanism of action of two pre-quit pharmacotherapies for smoking cessation
    Stuart G. Ferguson, Julia AE Walters, Wenying Lu, Gudrun Wells, Natalie Schüz · 2015 · BMC Public Health
  7. PSM3 AN EVALUATION OF THE COST-EFFECTIVENESS OF AN EXTENDED COURSE OF VARENICLINE IN PREVENTING SMOKERS WHO HAVE QUIT FROM RELAPSING
    C. R. Knight, PA Howard, CL Baker · 2007 · Value in Health
  8. Association of deferring a quit attempt with smoking cessation success: A secondary analysis
    John R. Hughes, Cristina Russ, Michael Messig · 2013 · Journal of Substance Abuse Treatment
  9. A new medication for the worst addiction
    Charles P. O’Brien · 2007 · Current Psychiatry Reports
  10. [Pharmacological agents in controlling smoking].
    V I Metelitsa · 1987 · PubMed
  11. [Smoking withdrawal treatment with Cytisin (Tabex). Results of a semi-annual survey of former smokers after 4 weeks of therapy].
    S Benndorf, G Scharfenberg, G Kempe, R Wendekamm, E Winkelvoss · 1970 · PubMed
  12. Comparison of the Effectiveness of Varenicline, Extended-Release Bupropion and Nicotine Replacement Therapy on The Success and the Maintenance of a Smoking Cessation Program
    Selma Bozkurt Zincir, Serkan Zincir, Esra Kaymak, Esra Aydın Sünbül · 2013 · Klinik Psikofarmakoloji Bülteni-Bulletin of Clinical Psychopharmacology
  13. PRS4 EFFECTIVENESS OF VARENICLINE COMPARED TO BUPROPION AND NICOTINE REPLACEMENT THERAPY (NRT) FOR SMOKING CESSATION IN TWO SMOKING SPECIALIZED UNITS OF THE SPANISH PRIMARY CARE SETTING
    Antoni Sicras‐Mainar, Ruth Navarro‐Artieda, Silvia Díaz‐Cerezo, de la Torre Sanz, V. Sanz de Burgoa · 2010 · Value in Health
  14. [Results of the smoking-habit breaking using cytisin (Tabex). I].
    S Bennodorf, G Kempe, G Scharfenberg, R Wendekamm, E Winkelvoss · 1968 · PubMed
  15. [Breaking the smoking habit using cytisin containing "Tabex" tablets].
    D Paun, J Franze · 1968 · PubMed
  16. Practical implementation of varenicline as an aid to smoking cessation in clinical practice.
    Serena Tonstad · 2009 · PubMed
  17. Smoking Cessation Interventions: A Primer for Physicians
    Joel A. Simon · 2011 · Archives of Internal Medicine
  18. Rationale and design of a randomized controlled trial of varenicline directly observed therapy delivered in methadone clinics
    Shadi Nahvi, Kate S. Segal, Alain H. Litwin, Julia Hope Arnsten · 2014 · Addiction Science & Clinical Practice
  19. Pre-cessation varenicline treatment vs post-cessation NRT: an uneven playing field.
    Jed E. Rose · 2008 · PubMed
  20. Clinically significant outcomes in smoking cessation.
    Toby Hillman, K Rajakulasingam, Angshu Bhowmik · 2008 · PubMed
  21. Varenicline for smoking cessation intervention in chronic obstructive pulmonary disease
    Sabina A Antoniu, Antigona Carmen Trofor · 2011 · Expert Opinion on Pharmacotherapy
  22. Errors in interpreting abstinence curves in studies of smoking cessation
    John Russell Hughes, PETER W. CALLAS · 2006 · Nicotine & Tobacco Research
  23. Study suggests varenicline safe and effective among adults with stable depression
    Paul M. Cinciripini, Maher Karam‐Hage · 2014 · BMJ Evidence-Based Medicine
  24. [Treatment of nicotinism].
    Marakulin Vs, V M Komarov, Chuprin Vv · 1984 · PubMed
  25. Varenicline Tartrate And Counselling Versus Counselling Alone In A Randomised Controlled Trial For Inpatient Smoking Cessation: 6 Month Interim Results
    Brian J. Smith, Matthew J. Peters, Robert Fitridge, Adrian J. Esterman, John Litt, John David Horowitz, Simon Andrea Koblar, Jim Jannes, Antony Veale, Sharon J. Goldsworthy et al. · 2011
  26. [Therapeutic use of Tabex].
    Laura E. Maliszewski, A Straczyński · 1972 · PubMed
  27. A second varenicline trial.
    Charles P. O’Brien · 2007 · PubMed
  28. Is Varenicline Effectiveness Declining in Randomized Trials?
    Ranjit K. Dhelaria · 2011 · Archives of Internal Medicine
  29. What Justifies a Placebo-Controlled Trial of Varenicline for Smoking Cessation in Patients With COPD?
    Daniel Kotz, Onno C. P. van Schayck · 2011 · CHEST Journal
  30. Use of the Patient Health Questionnaire‐2 to Predict Suicidal Ideations in Patients Taking Varenicline
    Christopher M. Cowan, Jennifer S. Wink, Kent J. DeZee · 2012 · American Journal on Addictions
  31. Response to Letter Regarding Article, “Efficacy and Safety of Varenicline for Smoking Cessation in Patients With Cardiovascular Disease: A Randomized Trial”
    Nancy A. Rigotti, Andrew Pipe, Neal L. Benowitz, Carmen Arteaga, Dahlia Garza, Serena Tonstad · 2010 · Circulation
  32. Varenicline: Smoking Cessation in Patients with Medical and Psychiatric Comorbidity
    Serena Tonstad, Charl Els · 2010 · Clinical Medicine Insights Therapeutics
  33. Is Varenicline Effectiveness Declining in Randomized Trials?—Reply
    Peter Hájek · 2011 · Archives of Internal Medicine
  34. GW25-e5131 Efficacy and Safety of Varenicline for Smoking Cessation in Patients with CAD undergoing PCI
    Yujie Wei, Liu Huliang · 2014 · Journal of the American College of Cardiology
  35. Cardiovascular and neuropsychiatric risks of varenicline: too good to be true?
    Neil M Davies, Gemma M. J. Taylor, Amy E. Taylor, Richard Michael Martin, Marcus Robert Munafo, Kyla H Thomas · 2015 · The Lancet Respiratory Medicine
  36. [Medical and technical characteristics of administering drugs via jet into the tracheal and bronchial wells].
    Melemukha, Gigauri Vs, Smoliarov Bv, Sarkisian Rs · 1973 · PubMed
  37. QUESTIONABLE CONCLUSIONS ON CANNABIS AND CRIME
    Anne Line Bretteville‐Jensen, Ingeborg Margrete Rossow · 2011 · Addiction
  38. Cytisine increased smoking cessation in adults
    Daniella A. Zipkin · 2012 · Annals of Internal Medicine
  39. Varenicline may reduce negative effect while aiding smoking cessation
    James Taylor Hays · 2013 · BMJ Evidence-Based Medicine
  40. Sa1222 Pharmacotherapy for Inflammatory Disorders and the Risk for Invasive Parasitic Infections: A Review of the Food and Drug Administration Adverse Event Reporting System (FDA AERS) From the REFURBISH Study
    Parakkal Deepak, Derrick J. Stobaugh, Eli D. Ehrenpreis · 2012 · Gastroenterology
  41. [Medicinal breaking of the smoking habit. Remarks to G. Scharfenberg, E. Winkelvosss and S. Benndorf. München Med Wschr. 109 (1967) 33, 1687-1689].
    V I Bâcvarov · 1967 · PubMed
  42. Others
    2015 · Respirology
  43. [Medicinal breaking of the smoking habit. Last reply to the remarks of V. Baucvarov, München Med Wschr 109 (1967) 50, 2663-2665].
    G Scharfenberg, E Winkelvoss, S Benndorf · 1967 · PubMed
  44. [Etiologic characteristics of the influenza epidemic of 1969].
    I A Shifrin, Shironin Li, I I Kamalov, Sgibov Ia, Tarasov Vv · 1968 · PubMed
  45. Cytisine increased smoking cessation in adults
    Robert West, Witold Antoni Zatoński · 2012 · UCL Discovery (University College London)